284493-56-7 Usage
Uses
Used in Pharmaceutical Industry:
3-N-BOC-3-(2-FLUOROPHENYL)PROPIONIC ACID is used as a key intermediate in the synthesis of peptide-based drugs for its ability to protect the peptide during the synthesis process. The BOC group ensures that the peptide remains stable and unreacted until the desired point in the synthesis, at which it can be selectively removed to yield the final drug product.
Used in Drug Design and Development:
3-N-BOC-3-(2-FLUOROPHENYL)PROPIONIC ACID is used as a building block in the design of novel pharmaceuticals, leveraging its fluorophenyl and propionic acid components to create molecules with specific chemical behaviors. The fluorination of the phenyl ring can influence the compound's reactivity, solubility, and interaction with biological targets, making it a valuable tool in the development of new therapeutic agents.
Used in Organic Chemistry Research:
3-N-BOC-3-(2-FLUOROPHENYL)PROPIONIC ACID is used as a model compound in organic chemistry research to study the effects of fluorination on the properties of aromatic rings. This can provide insights into the design of new molecules with tailored chemical and biological properties, contributing to the advancement of the field.
Check Digit Verification of cas no
The CAS Registry Mumber 284493-56-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,4,9 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 284493-56:
(8*2)+(7*8)+(6*4)+(5*4)+(4*9)+(3*3)+(2*5)+(1*6)=177
177 % 10 = 7
So 284493-56-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H18FNO4/c1-14(2,3)20-13(19)16-11(8-12(17)18)9-6-4-5-7-10(9)15/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)
284493-56-7Relevant academic research and scientific papers
BICYCLIC-PYRIMIDINEDIONE COMPOUNDS
-
Paragraph 0249; 0250, (2016/07/27)
The present invention provides novel bicyclic pyrimidinedione compounds that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds is described, as well as methods for treating HCM and other forms of heart disease.
